LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing,Cyclopentanohydrophenanthrene ring system doai

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

16-epiestriol to prevent, inhibit or reduce inflammation

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

16-epiestriol to prevent, inhibit, or reduce inflammation withou

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

16-substituted androstanes and 16-substituted androstenes

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17 .alpha.-(substituted-methyl)-17.beta.-hydroxy/esterified hydr

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17 substituted acyl-3-carboxy 3,5-diene steroidals as .alpha.-re

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17α-ALKYL-17β-OXY-ESTRATRIENES AND INTERMEDIATE...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17α-fluorosteroids, pharmaceutical compositions...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17α-hydroxy-14β-steroids with hormonal effect

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17β-amino and hydroxylamino-11 β-arylsteroids...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17β-HSD1 and STS inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17&agr;-fluoroalkyl-11&bgr;-benzaldoxime steroids, process...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17&bgr;-2-oxo-tetrahydrofuranyl)-carbothioic acid ester,...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17&bgr;-acyl-17&agr;-propynyl-11&bgr;-(cyclic amino) aryl...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17&bgr;-acyl-17&agr;-propynyl-11&bgr;-arylsteroids and their...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17&bgr;-amino and hydroxylamino-11&bgr;-arylsteroids and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17&bgr;-amino and hydroxylamino-11&bgr;-arylsteroids and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17-(3-furyl)-5.beta., 14.beta.-androstane derivatives active on

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17-(4-pyridazinyl) -5.beta., 14.beta.-androstane derivatives act

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17-.alpha.-acyl steroids which inhibit 5-.alpha.-reductase